The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

Keyphrases

• Chronic Myeloid Leukemia 100%
• Hybrid Genes 100%
• P210 100%
• C-Abl 60%
• Antiserum 40%
• Chronic Myelogenous Leukemia Cells 40%
• Phosphoprotein 40%
• Amino 20%
• Disease-associated 20%
• Human Disease 20%
• Fusion Protein 20%
• HeLa Cells 20%
• RNA Transcripts 20%
• Protein Drug 20%
• Murine Leukemia Virus 20%
• Chromosomal Translocation 20%
• Chromosome 22 20%
• K562 Cells 20%
• Chromosome 9 20%
• Fusion Transcript 20%
• Novel Products 20%

Biochemistry, Genetics and Molecular Biology

• Phosphoprotein 100%
• Hybrid Gene 100%
• N-Terminus 50%
• RNA 50%
• Abelson Murine Leukemia Virus 50%
• Chromosome 22 50%
• Chromosomal Translocation 50%
• Chromosome 9 50%
• K562 Cells 50%
• Fusion Transcript 50%
• Chimeric Protein 50%

Medicine and Dentistry

• Chronic Myelogenous Leukemia 100%
• Hybrid Gene 100%
• BCR ABL Protein 100%
• Leukemia Cell 40%
• Antiserum 40%
• Phosphoprotein 40%
• Disease 20%
• Amino Terminal Sequence 20%
• Chimeric Protein 20%
• K562 Cells 20%
• Chromosome 22 20%
• Chromosome Translocation 20%
• Chromosome 9 20%
• Transforming Protein 20%
• Abelson Murine Leukemia Virus 20%